DLK1-DIO3 imprinted cluster in induced pluripotency: Landscape in the mist

Cellular and Molecular Life Sciences

Volumn 71, Issue 22, 2014, Pages 4421-4430

  Benetatos, Leonidas ^a   Vartholomatos, George ^b   Hatzimichael, Eleftheria ^b  

^a Blood Bank Preveza General Hospital   (Greece)

^b UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

Author keywords

DLK1 DIO3; Genomic imprinting; Induced pluripotent stem cells; MEG3; MicroRNAs; Pluripotency; Reprogramming; Stem cells

Indexed keywords

KRUPPEL LIKE FACTOR 4; MICRORNA; TRANSCRIPTION FACTOR; DLK1 PROTEIN, HUMAN; IODIDE PEROXIDASE; MEMBRANE PROTEIN; SIGNAL PEPTIDE;

CARCINOGENESIS; CHROMOSOME 12Q; CHROMOSOME 14Q; DIO3 GENE; DLK1 GENE; DNA METHYLATION; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; GENE; GENE CLUSTER; GENE EXPRESSION; GENOME IMPRINTING; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HISTONE METHYLATION; HUMAN; MEG3 GENE; MEG8 GENE; NONHUMAN; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; REVIEW; RTL1 GENE; ENZYMOLOGY; GENETIC EPIGENESIS; GENETICS; METABOLISM;

CARCINOGENESIS; EPIGENESIS, GENETIC; GENOMIC IMPRINTING; HUMANS; INDUCED PLURIPOTENT STEM CELLS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; IODIDE PEROXIDASE; MEMBRANE PROTEINS; MICRORNAS; TRANSCRIPTION FACTORS;

EID: 84925287179     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-014-1698-9     Document Type: Review

References (86)

1. Ambrosio R, Damiano V, Sibilio A et al (2013) Epigenetic control of type 2 and 3 deiodinases in myogenesis: role of Lysine-specific Demethylase enzyme and FoxO3. Nucleic Acids Res 41:3551-3562
2. Andersen DC, Laborda J, Baladron V et al (2013) Dual role of delta-like 1 homolog (DLK1) in skeletal muscle development and adult muscle regeneration. Development 140:3743-3753
3. Andersen DC, Petersson SJ, Jorgensen LH et al (2009) Characterization of DLK1 + cells emerging during skeletal muscle remodeling in response to myositis, myopathies, and acute injury. Stem Cells 27:898-908
4. Argiropoulos B, Palmqvist L, Imren S et al (2010) Meis1 disrupts the genomic imprint of Dlk1 in a NUP98-HOXD13 leukemia model. Leukemia 24:1788-1791
5. Balik V, Srovnal J, Sulla I et al (2013) MEG3: a novel long noncoding potentially tumor-suppressing RNA in meningiomas. J Neurooncol 112:1-8
6. Barlow DP, Bartolomei MS (2014) Genomic imprinting in mammals. Cold Spring Harb Perspect Biol 6(2). doi: 10.1101/cshperspect.a018382
7. Begum A, Kim Y, Lin Q et al (2012) DLK1, delta-like 1 homolog (Drosophila), regulates tumor cell differentiation in vivo. Cancer Lett 318:26-33
8. Begum A, Lin Q, Yu C et al (2014) Interaction of delta-like 1 homolog (Drosophila) with prohibitins and its impact on tumor cell clonogenicity. Mol Cancer Res 12:155-164
9. Benetatos L, Dasoula A, Hatzimichael E et al (2008) Promoter hypermethylation of the MEG3 (DLK1/MEG3) imprinted gene in multiple myeloma. Clin Lymphoma Myeloma 8:171-175
10. Benetatos L, Hatzimichael E, Dasoula A et al (2010) CpG methylation analysis of the MEG3 and SNRPN imprinted genes in acute myeloid leukemia and myelodysplastic syndromes. Leuk Res 34:148-153
11. Benetatos L, Hatzimichael E, Londin E et al (2013) The microRNAs within the DLK1-DIO3 genomic region: involvement in disease pathogenesis. Cell Mol Life Sci 70:795-814
12. Benetatos L, Vartholomatos G, Hatzimichael E (2011) MEG3 imprinted gene contribution in tumorigenesis. Int J Cancer 129:773-779
13. Benetatos L, Voulgaris E, Vartholomatos G (2012) DLK1-MEG3 imprinted domain microRNAs in cancer biology. Crit Rev Eukaryot Gene Expr 22:1-15
14. Bock C, Kiskinis E, Verstappen G et al (2011) Reference Maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. Cell 144:439-452
15. Brandvain Y, Van Cleve J, Ubeda F et al (2011) Demography, kinship, and the evolving theory of genomic imprinting. Trends Genet 27:251-257
16. Carey BW, Markoulaki S, Hanna JH et al (2011) Reprogramming factor stoichiometry influences the epigenetic state and biological properties of induced pluripotent stem cells. Cell Stem Cell 9:588-598
17. Cheng D, Li Z, Liu Y et al (2012) Kinetic analysis of porcine fibroblast reprogramming toward pluripotency by defined factors. Cell Reprogram 14:312-323
18. Chou BK, Cheng L (2013) And then there were none: no need for pluripotency factors to induce reprogramming. Cell Stem Cell 13:261-262
19. Cui XS, Zhang DX, Ko YG et al (2009) Aberrant epigenetic reprogramming of imprinted microRNA-127 and Rtl1 in cloned mouse embryos. Biochem Biophys Res Commun 379:390-394
20. Da Rocha ST, Charalambous M, Lin SP et al (2009) Gene dosage effects of the imprinted delta-like homologue 1 (dlk1/pref1) in development: implications for the evolution of imprinting. PLoS Genet 5:e1000392
21. Doulatov S, Notta F, Laurenti E et al (2012) Hematopoiesis: a human perspective. Cell Stem Cell 10:120-136
22. Doulatov S, Vo LT, Chou SS et al (2013) Induction of multipotential hematopoietic progenitors from human pluripotent stem cells via respecification of lineage-restricted precursors. Cell Stem Cell 13:459-470
23. Dudek KM, Suter L, Darras VM et al (2013) Decreased translation of Dio3 mRNA is associated with drug-induced hepatotoxicity. Biochem J 453:71-82
24. Falix FA, Aronson DC, Lamers WH et al (2012) Possible roles of DLK1 in the Notch pathway during development and disease. Biochim Biophys Acta 1822:988-995
25. Ferron SR, Charalambous M, Radford E et al (2011) Postnatal loss of Dlk1 imprinting in stem cells and niche astrocytes regulates neurogenesis. Nature 475:381-385
26. Gu T, He H, Han Z et al (2012) Expression of macro non-coding RNAs Meg8 and Irm in mouse embryonic development. Acta Histochem 114:392-399
27. Gueller S, Komor M, Nowak D et al (2010) Identification of defects in the transcriptional program during lineage-specific in vitro differentiation of CD34(+) cells selected from patients with both low- and high-risk myelodysplastic syndrome. Exp Hematol 38:718-732 e711-716
28. Guglielmelli P, Zini R, Bogani C et al (2007) Molecular profiling of CD34+ cells in idiopathic myelofibrosis identifies a set of disease-associated genes and reveals the clinical significance of Wilms' tumor gene 1 (WT1). Stem Cells 25:165-173
29. Guo X, Liu Q, Wang G et al (2013) MicroRNA-29b is a novel mediator of Sox2 function in the regulation of somatic cell reprogramming. Cell Res 23:142-156
30. Henzler CM, Li Z, Dang J et al (2013) Staged miRNA re-regulation patterns during reprogramming. Genome Biol 14:R149
31. Hernandez A, Garcia B, Obregon MJ (2007) Gene expression from the imprinted Dio3 locus is associated with cell proliferation of cultured brown adipocytes. Endocrinology 148:3968-3976
32. Janssen R, Zuidwijk M, Muller A et al (2013) Cardiac expression of deiodinase type 3 (Dio3) following myocardial infarction is associated with the induction of a pluripotency microRNA signature from the Dlk1-Dio3 genomic region. Endocrinology 154:1973-1978
33. John RM, Lefebvre L (2011) Developmental regulation of somatic imprints. Differentiation 81:270-280
34. Kagami M, O'sullivan MJ, Green AJ et al (2010) The IG-DMR and the MEG3-DMR at human chromosome 14q32.2: hierarchical interaction and distinct functional properties as imprinting control centers. PLoS Genet 6:e1000992
35. Kameswaran V, Bramswig NC, Mckenna LB et al (2014) Epigenetic regulation of the DLK1-MEG3 microRNA cluster in human type 2 diabetic islets. Cell Metab 19:135-145
36. Kaneko S, Bonasio R, Saldana-Meyer R et al (2014) Interactions between JARID2 and noncoding RNAs regulate PRC2 recruitment to chromatin. Mol Cell 53:290-300
37. Kaneta M, Osawa M, Sudo K et al (2000) A role for pref-1 and HES-1 in thymocyte development. J Immunol 164:256-264
38. Kelley JM, Daley GQ (2013) Hematopoietic defects and iPSC disease modeling: lessons learned. Immunol Lett 155:18-20
39. Khoury H, Suarez-Saiz F, Wu S et al (2010) An upstream insulator regulates DLK1 imprinting in AML. Blood 115:2260-2263
40. Kim Y, Lin Q, Zelterman D et al (2009) Hypoxia-regulated delta-like 1 homologue enhances cancer cell stemness and tumorigenicity. Cancer Res 69:9271-9280
41. Langer F, Stickel J, Tessema M et al (2004) Overexpression of delta-like (Dlk) in a subset of myelodysplastic syndrome bone marrow trephines. Leuk Res 28:1081-1083
42. Li L, Forman SJ, Bhatia R (2005) Expression of DLK1 in hematopoietic cells results in inhibition of differentiation and proliferation. Oncogene 24:4472-4476
43. Li L, Liu B, Wapinski OL et al (2013) Targeted disruption of Hotair leads to homeotic transformation and gene derepression. Cell Rep 5:3-12
44. Li W, Zhao XY, Wan HF et al (2011) iPS cells generated without c-Myc have active Dlk1-Dio3 region and are capable of producing full-term mice through tetraploid complementation. Cell Res 21:550-553
45. Li X (2013) Genomic imprinting is a parental effect established in mammalian germ cells. Curr Top Dev Biol 102:35-59
46. Li Y, Sasaki H (2011) Genomic imprinting in mammals: its life cycle, molecular mechanisms and reprogramming. Cell Res 21:466-473
47. Liang G, Zhang Y (2013) Genetic and epigenetic variations in iPSCs: potential causes and implications for application. Cell Stem Cell 13:149-159
48. Liu L, Luo GZ, Yang W et al (2010) Activation of the imprinted Dlk1-Dio3 region correlates with pluripotency levels of mouse stem cells. J Biol Chem 285:19483-19490
49. Lujan E, Wernig M (2010) An imprinted signature helps isolate ESC-equivalent iPSCs. Cell Res 20:974-976
50. Luk JM, Burchard J, Zhang C et al (2011) DLK1-DIO3 genomic imprinted microRNA cluster at 14q32.2 defines a stemlike subtype of hepatocellular carcinoma associated with poor survival. J Biol Chem 286:30706-30713
51. Ma X, Zhang Y, Yang L et al (2012) The effects of increased expression of DLK1 gene on the pathogenesis of myelodysplastic syndromes. Clin Lymphoma Myeloma Leuk 12:261-268
52. Manodoro F, Marzec J, Chaplin T et al (2014) Loss of imprinting at the 14q32 domain is associated with microRNA overexpression in acute promyelocytic leukemia. Blood 123:2066-2074
53. Martin-Subero JI, Ammerpohl O, Bibikova M et al (2009) A comprehensive microarray-based DNA methylation study of 367 hematological neoplasms. PLoS One 4:e6986
54. Mcmurray EN, Schmidt JV (2012) Identification of imprinting regulators at the Meg3 differentially methylated region. Genomics 100:184-194
55. Mirshekar-Syahkal B, Haak E, Kimber GM et al (2013) Dlk1 is a negative regulator of emerging hematopoietic stem and progenitor cells. Haematologica 98:163-171
56. Nishino K, Toyoda M, Yamazaki-Inoue M et al (2011) DNA methylation dynamics in human induced pluripotent stem cells over time. PLoS Genet 7:e1002085
57. Pick M, Stelzer Y, Bar-Nur O et al (2009) Clone- and gene-specific aberrations of parental imprinting in human induced pluripotent stem cells. Stem Cells 27:2686-2690
58. Radford EJ, Ferron SR, Ferguson-Smith AC (2011) Genomic imprinting as an adaptative model of developmental plasticity. FEBS Lett 585:2059-2066
59. Riordan JD, Keng VW, Tschida BR et al (2013) Identification of rtl1, a retrotransposon-derived imprinted gene, as a novel driver of hepatocarcinogenesis. PLoS Genet 9:e1003441
60. Robinton DA, Daley GQ (2012) The promise of induced pluripotent stem cells in research and therapy. Nature 481:295-305
61. Schneider G, Bowser MJ, Shin DM et al (2014) The paternally imprinted DLK1-GTL2 locus is differentially methylated in embryonal and alveolar rhabdomyosarcomas. Int J Oncol 44:295-300
62. Seisenberger S, Peat JR, Reik W (2013) Conceptual links between DNA methylation reprogramming in the early embryo and primordial germ cells. Curr Opin Cell Biol 25:281-288
63. Sekita Y, Wagatsuma H, Nakamura K et al (2008) Role of retrotransposon-derived imprinted gene, Rtl1, in the feto-maternal interface of mouse placenta. Nat Genet 40:243-248
64. Semi K, Matsuda Y, Ohnishi K et al (2013) Cellular reprogramming and cancer development. Int J Cancer 132:1240-1248
65. Sommer CA, Christodoulou C, Gianotti-Sommer A et al (2012) Residual expression of reprogramming factors affects the transcriptional program and epigenetic signatures of induced pluripotent stem cells. PLoS One 7:e51711
66. Soubry A, Murphy SK, Wang F et al (2013) Newborns of obese parents have altered DNA methylation patterns at imprinted genes. Int J Obes (Lond). doi: 10.1038/ijo.2013.193
67. Stadtfeld M, Apostolou E, Akutsu H et al (2010) Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells. Nature 465:175-181
68. Stadtfeld M, Apostolou E, Ferrari F et al (2012) Ascorbic acid prevents loss of Dlk1-Dio3 imprinting and facilitates generation of all-iPS cell mice from terminally differentiated B cells. Nat Genet 44(398-405):S391-S392
69. Sul HS (2009) Minireview: Pref-1: role in adipogenesis and mesenchymal cell fate. Mol Endocrinol 23:1717-1725
70. Takahashi N, Kobayashi R, Kono T (2010) Restoration of Dlk1 and Rtl1 is necessary but insufficient to rescue lethality in intergenic differentially methylated region (IG-DMR)-deficient mice. J Biol Chem 285:26121-26125
71. Takikawa S, Ray C, Wang X et al (2013) Genomic imprinting is variably lost during reprogramming of mouse iPS cells. Stem Cell Res 11:861-873
72. Traustadottir GA, Kosmina R, Sheikh SP et al (2013) Preadipocytes proliferate and differentiate under the guidance of Delta-like 1 homolog (DLK1). Adipocyte 2:272-275
73. Venkatraman A, He XC, Thorvaldsen JL et al (2013) Maternal imprinting at the H19-Igf2 locus maintains adult haematopoietic stem cell quiescence. Nature 500:345-349
74. Vlantis K, Wullaert A, Sasaki Y et al (2011) Constitutive IKK2 activation in intestinal epithelial cells induces intestinal tumors in mice. J Clin Invest 121:2781-2793
75. Wesemann DR, Portuguese AJ, Magee JM et al (2012) Reprogramming IgH isotype-switched B cells to functional-grade induced pluripotent stem cells. Proc Natl Acad Sci USA 109:13745-13750
76. Wolf JB (2013) Evolution of genomic imprinting as a coordinator of coadapted gene expression. Proc Natl Acad Sci USA 110:5085-5090
77. Xie P, Sun Y, Ouyang Q et al (2014) Physiological oxygen prevents frequent silencing of the DLK1-DIO3 cluster during human embryonic stem cells culture. Stem Cells 32:391-401
78. Xu X, Liu RF, Zhang X et al (2012) DLK1 as a potential target against cancer stem/progenitor cells of hepatocellular carcinoma. Mol Cancer Ther 11:629-638
79. Yamaguchi S, Shen L, Liu Y et al (2013) Role of Tet1 in erasure of genomic imprinting. Nature 504:460-464
80. Yanai H, Nakamura K, Hijioka S et al (2010) Dlk-1, a cell surface antigen on foetal hepatic stem/progenitor cells, is expressed in hepatocellular, colon, pancreas and breast carcinomas at a high frequency. J Biochem 148:85-92
81. Yang SM, Kim BJ, Norwood Toro L et al (2013) H1 linker histone promotes epigenetic silencing by regulating both DNA methylation and histone H3 methylation. Proc Natl Acad Sci USA 110:1708-1713
82. Yue LZ, Fu R, Wang HQ et al (2012) Expression of DLK1 Gene in the Bone Marrow Cells of Patients with Myelodysplastic Syndromes and Its Clinical Significance. Cancer Biol Med 9:188-191
83. Zhang W, Shao Z, Fu R et al (2013) Effect of DLK1 on tumorigenesis in CD34CD38 bone marrow cells in myelodysplastic syndromes. Oncol Lett 6:203-206
84. Zhao J, Ohsumi TK, Kung JT et al (2010) Genome-wide identification of polycomb-associated RNAs by RIP-seq. Mol Cell 40:939-953
85. Zhou Y, Zhang X, Klibanski A (2014) Genetic and epigenetic mutations of tumor suppressive genes in sporadic pituitary adenoma. Mol Cell Endocrinol 386:16-33
86. Zhou Y, Zhang X, Klibanski A (2012) MEG3 noncoding RNA: a tumor suppressor. J Mol Endocrinol 48:R45-R53